Pharmaceuticals, Biotechnology and Life Sciences
MILWAUKEE–(BUSINESS WIRE)–Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and colors for the food, pharmaceutical, and personal care…
PALO ALTO, Calif. & NEW YORK–(BUSINESS WIRE)–Evommune, Inc. (“Evommune” or the “Company”) (NYSE: EVMN), a clinical-stage biotechnology company developing innovative…
CHICAGO–(BUSINESS WIRE)–The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per…
PALISADE-4 Phase 3 Trial of fasedienol for acute treatment of Social Anxiety Disorder proceeding, with topline results from the randomized…
AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PT/4:30 p.m.…
DUBLIN–(BUSINESS WIRE)–$PRTA #Prothena–Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on…
— Full year total revenue of $12.0 billion, a 9% increase compared to full year 2024; fourth quarter total revenue…
EMMI Predict: TerraBind Solves Critical Computational Bottleneck in AI-driven Drug Discovery LOS ANGELES–(BUSINESS WIRE)–#biotech–Terray Therapeutics today unveiled the latest EMMI…
New members bring world-class clinical expertise to guide Phase 1b trial of TP-317 in ulcerative colitis ESSEX, Conn.–(BUSINESS WIRE)–#IBD–Thetis Pharmaceuticals,…